SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRLS - Chrysalis : Any followers ? Any comments ?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sleepman who wrote (27)11/10/1997 1:13:00 PM
From: BulbaMan  Read Replies (1) of 51
 
I found two Wall Street Journal articles on the cloning of Dolly that mention Chrysalis. Both articles quote Paul Schmitt, Chrysalis CEO, with the WSJ describing Chrysalis as: "The drug-research company (that) holds a patent on the 'microinjection' technique that is commonly used in animal genetic engineering."
In addition, Schmitt noted that Chrysalis had licensing arrangements for its DNA microinjection technology with 30 different companies, including PPL (Dolly's daddies).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News